| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.002 |